FDA Targets 20 Over Unapproved Drugs
(AP) -- Manufacturers of unapproved extended-release cough and cold drugs that contain an expectorant called guaifenesin have until Nov. 25 to stop shipping the medicines, health officials said Friday.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
» Next Article in Medicine & Health - Medications: Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage

Rating: n/a
Bookmark
Save as PDF
Print
Email
Blog It
Stumble It!


PhysOrg Forum
Video
Editorials
Free Magazines
Free White Papers
Newsletter
Advanced Search
Goto Archive
Suggest a story idea
Send feedback